169 related articles for article (PubMed ID: 32856602)
21. The prognostic importance of scalp location in primary head and neck melanoma.
Ozao-Choy J; Nelson DW; Hiles J; Stern S; Yoon JL; Sim MS; Faries MB
J Surg Oncol; 2017 Sep; 116(3):337-343. PubMed ID: 28543136
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous melanoma. Prognostic classification of anatomic location.
Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
Cancer; 1995 May; 75(10):2492-8. PubMed ID: 7736393
[TBL] [Abstract][Full Text] [Related]
23. Malignant melanoma arising in a sebaceous nevus of the scalp.
Abe S; Yamamoto Y; Uno S; Andou M; Akasaka T; Mihm MC
Br J Plast Surg; 2003 Mar; 56(2):171-3. PubMed ID: 12791367
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in nevus-associated genes MTAP, PLA2G6, and IRF4 and the risk of invasive cutaneous melanoma.
Kvaskoff M; Whiteman DC; Zhao ZZ; Montgomery GW; Martin NG; Hayward NK; Duffy DL
Twin Res Hum Genet; 2011 Oct; 14(5):422-32. PubMed ID: 21962134
[TBL] [Abstract][Full Text] [Related]
25. Primary melanoma location on the scalp is an important risk factor for brain metastasis: a study of 1,687 patients with cutaneous head and neck melanomas.
Huismans AM; Haydu LE; Shannon KF; Quinn MJ; Saw RP; Spillane AJ; Stretch JR; Thompson JF
Ann Surg Oncol; 2014 Nov; 21(12):3985-91. PubMed ID: 24912613
[TBL] [Abstract][Full Text] [Related]
26. IRF4 rs12203592 functional variant and melanoma survival.
Potrony M; Rebollo-Morell A; Giménez-Xavier P; Zimmer L; Puig-Butille JA; Tell-Marti G; Sucker A; Badenas C; Carrera C; Malvehy J; Schadendorf D; Puig S
Int J Cancer; 2017 Apr; 140(8):1845-1849. PubMed ID: 28103633
[TBL] [Abstract][Full Text] [Related]
27. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls.
Chang YM; Barrett JH; Bishop DT; Armstrong BK; Bataille V; Bergman W; Berwick M; Bracci PM; Elwood JM; Ernstoff MS; Gallagher RP; Green AC; Gruis NA; Holly EA; Ingvar C; Kanetsky PA; Karagas MR; Lee TK; Le Marchand L; Mackie RM; Olsson H; Østerlind A; Rebbeck TR; Sasieni P; Siskind V; Swerdlow AJ; Titus-Ernstoff L; Zens MS; Newton-Bishop JA
Int J Epidemiol; 2009 Jun; 38(3):814-30. PubMed ID: 19359257
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the prognostic significance of the site of origin of cutaneous melanoma.
Law MM; Wong JH
Am Surg; 1994 May; 60(5):362-6. PubMed ID: 8161088
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for limb melanomas compared with trunk melanomas in Queensland.
Green AC; Siskind V
Melanoma Res; 2012 Feb; 22(1):86-91. PubMed ID: 22124166
[TBL] [Abstract][Full Text] [Related]
30. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
31. Hypothesis: hair cover can protect against invasive melanoma on the head and neck (Australia).
Green AC; Kimlin M; Siskind V; Whiteman DC
Cancer Causes Control; 2006 Dec; 17(10):1263-6. PubMed ID: 17111257
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous head and neck melanoma (CHNM): A population-based study of the prognostic impact of tumor location.
Helsing P; Robsahm TE; Vos L; Rizvi SM; Akslen LA; Veierød MB
J Am Acad Dermatol; 2016 Nov; 75(5):975-982.e2. PubMed ID: 27546291
[TBL] [Abstract][Full Text] [Related]
33. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
34. Age-related lymphatic dysfunction in melanoma patients.
Conway WC; Faries MB; Nicholl MB; Terando AM; Glass EC; Sim M; Morton DL
Ann Surg Oncol; 2009 Jun; 16(6):1548-52. PubMed ID: 19277787
[TBL] [Abstract][Full Text] [Related]
35. Incidence of Cutaneous Melanoma of Eyelid Analysis of the Surveillance, Epidemiology, and End Results Database.
Brunetti P; Margo CE; French DD
Ocul Oncol Pathol; 2021 Mar; 7(1):66-69. PubMed ID: 33796520
[TBL] [Abstract][Full Text] [Related]
36. Trends in cutaneous malignant melanoma in Denmark 1943-1982 by anatomic site.
Osterlind A; Engholm G; Jensen OM
APMIS; 1988 Nov; 96(11):953-63. PubMed ID: 3196476
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis.
Gardner LJ; Ward M; Andtbacka RHI; Boucher KM; Bowen GM; Bowles TL; Cohen AL; Grossmann K; Hitchcock YJ; Holmen SL; Hyngstrom J; Khong H; McMahon M; Monroe MM; Ross CB; Suneja G; Wada D; Grossman D
Melanoma Res; 2017 Oct; 27(5):477-484. PubMed ID: 28800031
[TBL] [Abstract][Full Text] [Related]
38. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma.
Whiteman DC; Watt P; Purdie DM; Hughes MC; Hayward NK; Green AC
J Natl Cancer Inst; 2003 Jun; 95(11):806-12. PubMed ID: 12783935
[TBL] [Abstract][Full Text] [Related]
39. Desmoplastic malignant melanoma of the scalp.
Calista D
G Ital Dermatol Venereol; 2009 Jun; 144(3):329-30. PubMed ID: 19528915
[No Abstract] [Full Text] [Related]
40. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.
Olsen CM; Zens MS; Stukel TA; Sacerdote C; Chang YM; Armstrong BK; Bataille V; Berwick M; Elwood JM; Holly EA; Kirkpatrick C; Mack T; Bishop JN; Østerlind A; Swerdlow AJ; Zanetti R; Green AC; Karagas MR; Whiteman DC
Int J Cancer; 2009 Feb; 124(4):937-44. PubMed ID: 19035450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
